In addition, α-SMA, TGF-β, Col-1, and Col-4 can be regulated to prevent liver fibrosis, prevent the risk of complications, and improve the patient’s quality of life and prognosis. This evidence concerns the gene ACTA1 and Hepatic fibrosis.